Immuno-Biological Laboratories Co., Ltd. (4570.T)
JPY 496.0
(-0.2%)
JPY 496.0
(-0.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 104.29 Million JPY | 78.68% |
| 2022 | 58.37 Million JPY | 147.76% |
| 2021 | -122.21 Million JPY | 49.28% |
| 2020 | -240.98 Million JPY | 59.57% |
| 2019 | -596 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 52 Million JPY | -44.41% |
| 2023 Q3 | -3.86 Million JPY | -127.53% |
| 2023 Q1 | 576 Thousand JPY | -98.54% |
| 2023 Q4 | 93.54 Million JPY | 2518.3% |
| 2023 FY | 104.29 Million JPY | 78.68% |
| 2023 Q2 | 14.05 Million JPY | 2339.41% |
| 2022 Q3 | 73.45 Million JPY | 285.0% |
| 2022 FY | 58.37 Million JPY | 147.76% |
| 2022 Q4 | 39.48 Million JPY | -46.24% |
| 2022 Q2 | -39.7 Million JPY | 0.0% |
| 2021 FY | -122.21 Million JPY | 49.28% |
| 2020 FY | -240.98 Million JPY | 59.57% |
| 2019 FY | -596 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 82.524% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | 120.991% |
| GNI Group Ltd. | 13.1 Billion JPY | 99.204% |
| Linical Co., Ltd. | 725.72 Million JPY | 85.628% |
| Trans Genic Inc. | 89.43 Million JPY | -16.619% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 107.314% |
| Soiken Holdings Inc. | -610 Million JPY | 117.098% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | 113.497% |
| AnGes, Inc. | -11.96 Billion JPY | 100.872% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 109.306% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 101.095% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | 112.066% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 109.338% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 108.265% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | 113.061% |
| RaQualia Pharma Inc. | -337.36 Million JPY | 130.916% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 108.654% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 107.809% |
| PeptiDream Inc. | 6.77 Billion JPY | 98.46% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 105.404% |
| Ribomic Inc. | -1.11 Billion JPY | 109.344% |
| SanBio Company Limited | -4.53 Billion JPY | 102.298% |
| Healios K.K. | -3.37 Billion JPY | 103.087% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 109.03% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 107.485% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 107.434% |
| StemRIM | -2.07 Billion JPY | 105.024% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 91.461% |
| FunPep Company Limited | -994 Million JPY | 110.493% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 111.735% |
| Stella Pharma Corporation | -760.3 Million JPY | 113.718% |
| TMS Co., Ltd. | -943.25 Million JPY | 111.057% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 113.451% |
| Cuorips Inc. | -588.48 Million JPY | 117.723% |
| K Pharma,Inc. | 366.05 Million JPY | 71.507% |
| Takara Bio Inc. | 3 Billion JPY | 96.527% |
| ReproCELL Incorporated | -409.29 Million JPY | 125.483% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | -842.773% |
| StemCell Institute Inc. | 413.75 Million JPY | 74.792% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 27.824% |
| CellSeed Inc. | -697.77 Million JPY | 114.947% |